Airway management and manipulation of the cerebral circulation are the two cornerstones in preventing impending brain herniation in acutely decompensating patients. Thus, the anaesthetist will frequently play a key role in handling these patients. Aggressive management will often be highly rewarding because effective treatment for the underlying pathology can result in complete recovery.
initial spatial compensation for an increased volume of one of the intracranial components there are no intercompartmental pressure gradients. As transtentorial herniation begins, a pressure gradient develops between the supratentorial and the infratentorial compartment. Ventricular pressure at this point is approximately 20 mmHg. In the last stage (once herniation is complete) the supratentorial pressure rises rapidly.
Cerebrovascular factors and acute arterial hypertension
Changes in systemic blood pressure between mean arterial pressures of 50 and 150mmHg have little effect on cerebral blood flow or volume in cerebrovascular beds that retain autoregulation. However, with many mass lesions there may be loss of autoregulation, sometimes in areas of brain much larger than the actual lesion) In areas around neoplasms, abscesses, cerebral infarcts, and contusions, blood flow varies passively with systemic arterial pressure. In addition to causing brain engorgetaunt, arterial hypertension will increase fluid transudation in regions of vasogenic oedema. 6 Thus acute arterial hypertension may greatly increase brain bulk, causing increased brain shift and sharply increased ICE The significance of a transient increase in ICP is obvious. Once a transtentorial pressure gradient has developed, any increase in supratentorial volume may cause large rises in supratentorial pressure, with increased gradients leading to brain shift and acute herniation.
Intracranial pressure control
Treatment of acute herniation depends upon reducing intracranial CSF, blood or tissue volume. The factors that determine cerebral blood volume are those that affect the vascular tone in the brain. A recently modified hydraulic model of the cerebrovascular bed 7 which assigns an inflow and an outflow resistance on either side of a distensible tube (Figure 1 ) has been used to predict the effects on ICP of changes in the vasculature. In this model it is assumed that ICP closely approximates venous outflow pressure (Pv). , the ICP will vary indirectly with the inflow resistance. Although it is possible for an increase in outflow resistance to offset a decrease in inflow resistance in this model, this situation would occur only as ICP approaches arterial pressure. It therefore follows that conditions that decrease Ri (vasodilators) will lead to increases in ICP and CBF, while conditions that increase Ri (vasoconstrictors) will decrease ICP.
A major determinant of Ri and cerebral blood flow is the partial pressure of CO2 in the arterial blood. The effects of PaCOz on CBF depend on the direct action of the [H +] in the cerebral interstitial fluid upon the smooth muscle of cerebral arterioles. When CBF is altered by changes in PaCO~, there is a non-linear correlation between CBF and CBV. s Thus one of the cornerstones of acute ICP control is the reduction of CBV by acute respiratory alkalosis. Clinically both the high ICP and the signs of acute transtentorial herniation may be reversed by hypocapnia. 9'1~ Hyperventilation reduces CBF with no effect on cerebral metabolism, but when PaCO2 is lowered below 25 mmHg, increases in cerebral a-v DO2 may herald the onset of ischaemia. ~1 Hypotension has been shown to have an additive effect in reducing CBF and increasing biochemical markers of ischaemia in hypocapnic anaesthetized dogs. 12 During chronic respiratory alkalosis, CSF pH returns towards normal because of loss of bicarbonate from the CSF and a new equilibrium is established within 6-24 hours. 13 Although the effectiveness of hypocapnia in controlling ICP may diminish during this period, a return to normoventilafion will cause cerebral vasodilation. Therefore if normocapnia is desired, the patient's clinical condition or preferably his ICP should be monitored closely during the change.
The mode of ventilation is an important factor in ICP control. During controlled ventilation, efforts must be made to minimize the transmission of the increase in intrathoracic pressure to the cerebral venous circulation. A 15-30 degree head-up position will decrease the effects of intrathoracic pressure on ICP and allow 5-10 cm H20 of positive end expiratory pressure (PEEP) to be applied to the airway with minimal increase in ICP. ~4 The published human data on this subject were reviewed by Cooper et al.,15 who concluded that the application of up to 10cm H20 PEEP for the correction of hypoxaemia was not likely to affect the ICP adversely in appropriately managed patients. However, they recommended that the ICP should be monitored in patients to whom PEEP was applied to detect the occasional patient in whom it increased. Although high-frequency ventilation (HFV) has been shown to produce lesser increases in mean airway pressure than conventional ventilation, it does not appear to be advantageous in patients with high ICP. I6
Tracheal intubation
Although tracheal intubation is necessary for any prolonged ventilatory therapy, it may not be the first manoeuvre to be performed in the patient with acutely increased [CP. Airway obstruction and hypoventilation are common in decompensating patients. Reversal of the resultant hypoxia and hypercarbia can be achieved with mild hyperventilation by bag and mask and this may lead to substantial improvement before intubation. If the patient's condition permits, steps should be taken to limit the rise of ICP which occurs with tracheal intubation. Reduction of brain bulk with osmotic diuretics will produce a rapid improvement in intracranial compliance) Mannitol in doses of 0.25-2 g .kg-i acts non-specifically to decrease ICP by removing water from brain that has normal permeability characteristics.~7 If the patient has a ventficulostomy in place, then this may he used for CSI: removal before intubation and also for measuring ICP.
ha the absence of contraindications, good intubafing conditions should be provided with thiopentone and a muscle relaxant. If succinylcholine is chosen, then an appropriate "defasciculating" dose of non-depolarizing relaxant has been shown to prevent the increase in ICP associated with the administration of succinylcholine alone. ~s With the use of a barbiturate-succinylcholine sequence in patients with intracranial masses, the increase in ICP associated with endotracheal intubation has been observed to be 50 to 100 mmHg. 19'2~ These changes in ICP were accompaArcher: INTRACRANIAL PRESSURE AND THE ANAESTHETIS'r $53 nied by increases in mean arterial pressure such that cerebral perfusion pressure was largely unchanged. The administration of lidocaine 2t or a second dose of thinpentone 22 before intubation has been reported to blunt these rises in ICE It is particularly important to reassess the depth of anaesthesia before intubation when a longacting muscle relaxant is used to facilitate intubation, since the effects of a sleep dose of barbiturate at induction may be wearing off. A thiopentone infusion (14 mg' kg -I -hr -t) has been used to decrease CBF for up to one hour in spontaneously breathing patients, z3
Effects of anaesthetic agents on ICP When anaesthetizing patients with increased ICP, it is important to choose a technique suited to the control of imtracranial pressure and brain swelling. Neuroleptanaesthesia using a combination of nitrous oxide, oxygen, fentanyl and droperidol combined with mild hypervenfilation has been popular as it provides excellent neurosurgical conditions. Systemic hypertension is a common problem with neuroleptanaesthesia, and the addition of volatile agents such as halothane and isoflurane in 0.5-1 MAC doses offers both better blood p~essure control and decreased patient recall. Although halothane is a potent cerebral vasodilator and has been shown to increase ICP in humans za and to aggravate brain shift in experimental animals, 2s hypoeapnia induced before the agent has been added blunts the increase in ICP. z' Isoflurane has been proposed as a volatile anaesthetic superior to halothane for use in neurosurgical patients in part because ICP increases less with isoflurane than with halothane. In studies of patients with mass lesions, ICP changed little if isoflurane was added to a standard barbiturate-narcotic induction sequence in hyperventilated patients. 27'28 Since these patients have usually been treated with steroids before surgery, few have critically increased ICP when anaesthesia is induced and therefore may not be ideal for observing increases in ICP. With experimentally increased 1CP, three studies using cryogenic freezing lesions to cause an intracranial mass with oedema failed to demonstrate any difference in the effect on ICP of isoflurane, halothane, and enflurane} 9-31 Although brain protrusion through a craniotomy was less with isoflurane 22 than with halothane, some protrusion did occur. Grosslight et al. 3~ noted that increases in ICP from 5-13 mmHg occurred when isoflurane was administered to hyperventilated patients with brain tumours. Also, those at risk for ICP increase could be identified by a midline shift of brain structures on the CT scan. Since increases in ICP as small as 5-10mmHg have been shown to be associated with the development of anisocoriaY isoflurane may not be completely benign in patients at risk for brain shift, particularly those who demonstrate signs of rostrocaudal deterioration despite spontaneous or induced hypocapnia.
Prolonged control of elevated intracranial pressure
The benefit of controlling ICP with medical measures in conditions such as Reye's syndrome, near-drowning, and head injury remains uncertain. These patient populations are very heterogeneous and improvement in mortality and morbidity through aggressive ICP control has not been clearly demonstrated. Clinicians are in general more optimistic when the pathophysiology of the increased ICP does not involve structural brain damage (cerebral oedema following otherwise uneventful arteriovenous malformation excision) than when there is diffuse brain injury. However, completely reliable methods for selecting patients who might benefit from aggressive therapy have yet to be discovered. Recently Piatt and Schiff 34 have reviewed the use of high-dose barbiturates in neurosurgery.
In summary, an aggressive approach to reverse rostrocaudal deterioration and reduce intracranial pressure is essential during the acute management of patients with treatable intracranial pathology. Methods to increase intracranial compliance should be instituted before stimuli such as endotraeheal intubation are applied. If possible the use of volatile anaesthetics should be avoided in the patient at risk of increased ICE Isoflurane may cause significant increases in ICP even in hyperventilated patients.
